Fish & Richardson likes a dual perspective on appeal. It commonly uses the firm lawyer who ran the trial to present oral arguments — with the help of a fresh take from at least one attorney in the firm’s appellate practice. “We don’t have people [at the firm] who come in and argue the appeal after the district court case,” Minneapolis partner Jonathan Singer said.
The firm’s work for Allergan PLC has followed that pattern, Singer said. In August, the U.S. Court of Appeals for the Federal Circuit affirmed a win that blocks competitors from selling a generic version of the Lumigan glaucoma treatment until 2027.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
